报告地点：生命科学楼B619报告厅

报告概要：Infectious diseases and cancer are major “Killers” worldwide. The demands of rapid, accurate and low-cost early diagnosis of these diseases are challenging conventional diagnostic methods, especially in low-resource settings. Recently, fast growing microfluidic lab-on-a-chip and nanotechnologies have caused significant impact on modern disease diagnostics. Herein, I will highlight several paper/polymer hybrid microfluidic devices and nano-biosensing techniques that we recently developed for rapid disease diagnosis, especially in resource-poor settings. Difference chip substrates have different advantages as well as limitations. Paper/polymer hybrid microfluidic devices can draw more benefits from both substrates. Integrated graphene oxide nano-biosensors, on-chip DNA amplification and immunoassay, and nanoparticle-mediated photothermal immunosensing will be discussed toward their applications in point-of-care infectious disease diagnosis and cancer biomarker detection.